Kheiron Medical
AI enhanced cancer detection tools for radiologists
- 21-100 employees
- Healthcare
- B2B
- Artificial Intelligence
- Deep Tech
- Biology
- Data Analysis
- London, UK
Jump to section
Company mission
To give patients a better fighting chance against cancer using deep learning technology that works with radiologists.
Our take
Kheiron is a medical technology company that uses advanced machine learning to develop and deliver intelligent tools for radiologists, radiology departments, imaging centres and hospitals. Its tools and services improve the efficiency, consistency and accuracy of radiology reporting.
The company has made significant breakthroughs with its breast cancer screening product, Mia, but this was just the beginning of its journey. According to external clinical trial results, Kheiron’s deep learning technology achieves state-of-the-art malignancy detection support in breast cancer screening.
Ultimately Kheiron wants to radically improve the outcomes for cancer patients by pioneering a new era of, what they call, precision radiology.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Mental health support through Spill
- Extended parental leave
- Cycle to work scheme
- Equity to make you a partner in our commercial success
- Work from home opportunities
- Health insurance
Funding (last 2 of 3 rounds)
Jul 2019
$21.5m
SERIES A
Oct 2018
$0.1m
GRANT
Total funding: $34.3m
This company has top investors
Leadership
Peter Kecskemethy
(CEO)Previously PhD Researcher at University of Oxford for 6 years and Teaching Assistant at University of Reading for 1 year.
Tobias Rijken
(CTO)Previously Founding Director at The Young Consultant for 1 year and Co-founder & Head of Data Science at 42 Education.